The company we review in this report provides value-based care exclusively to Medicare eligible patients, and it is improving outcomes and reducing costs. The business is attractive as a long-term investment, however it is setting up nicely for a high-income-generating options trade. We believe the trade described in this report is an attractive one to place today and potentially over the next few trading sessions, as long as the underlying share price doesn’t move too dramatically before then.